Lemonade, Inc. (LMND) is a New York-based digital insurance company that uses artificial intelligence and machine learning to underwrite and service policies across renters, homeowners, auto, pet, and life insurance. Shares surged roughly +10% during Tuesday's session, rising from Monday's closing price of $57.74 to approximately $63.51 intraday. The price rally was triggered by a high-profile analyst upgrade from Morgan Stanley, which lifted its rating on LMND to 'Overweight' and raised its price target to $85 from $80, pointing to the company's expanding Tesla FSD partnership as a key differentiator in the autonomous vehicle insurance market.
The primary driver behind today's move is Morgan Stanley's decision to upgrade LMND to 'Overweight,' marking a significant shift in the firm's stance on the stock. The bank raised its price target to $85 from $80, explicitly citing Lemonade's emerging collaboration with Tesla (TSLA) as a catalyst that "could meaningfully improve" the company's long-term earnings profile. Morgan Stanley also noted that the autonomous vehicle insurance opportunity positions LMND ahead of traditional competitors who lack access to real-time vehicle telemetry data.
In January 2026, Lemonade launched a first-of-its-kind insurance product tailored for Tesla vehicles operating on Full Self-Driving (FSD) technology, initially rolling out in Arizona and Oregon. The partnership gave LMND exclusive access to Tesla vehicle data, which showed that FSD-equipped cars are involved in significantly fewer accidents — enabling the company to offer per-mile rates roughly 50% lower than standard auto insurance. Analysts expect the company to deepen its exposure to autonomous driving over time, potentially scaling the platform substantially as FSD adoption grows.
Lemonade's strong Q4 2025 results, reported in February 2026, continue to lend credibility to today's bullish momentum. The company reported an EPS loss of just $0.29 versus the consensus estimate of $0.40, while revenue came in at $228.1 million — up 53.3% year-over-year and above the $218 million estimate. In-force premiums grew 31% year-over-year to a record $1.24 billion, marking the ninth consecutive quarter of IFP growth acceleration. Management also raised guidance, projecting Q1 2026 revenue of $246–$251 million and full-year 2026 revenue of approximately $1.2 billion — both above prior Wall Street consensus.
LMND carries a notably elevated short interest, a condition that has repeatedly amplified price swings in either direction. The Morgan Stanley upgrade and positive fundamental backdrop appear to be triggering fresh short covering, adding fuel to the upward move beyond what analyst sentiment alone would typically generate. This dynamic is consistent with the stock's pattern around prior catalysts — shares surged nearly 18% in pre-market trading following the Q4 earnings release, and jumped over 13% when the Tesla FSD insurance product was announced in January.
Today's advance is occurring largely independent of broad market direction, reflecting stock-specific fundamental and analyst-driven momentum. The broader insurance technology sector has been recovering in 2026 after a volatile late-2025 period. Volume in LMND is running above its average daily levels, consistent with institutional repositioning following the upgrade. The stock has seen a range of $59.44 to $62.75 so far in the session, and is trading well above its 30-day moving average after a mid-February pullback that brought it from nearly $74 to the low $50s.
For traders looking to navigate volatile, high-momentum stocks like LMND, Tickeron's Trending AI Robots page offers a curated selection of top-performing AI trading bots — filtered specifically for current market conditions. Tickeron operates hundreds of AI bots covering thousands of tickers, each varying by strategy, timeframe, risk tolerance, and performance metrics. Rather than scrolling through every available option, the Trending AI Robots section surfaces only those bots that are demonstrating the strongest results right now. Whether you prefer swing trading, momentum strategies, or mean-reversion approaches, the platform provides data-driven tools to help match your style. Traders seeking an edge in fast-moving stocks may find this resource worth exploring.
The next major fundamental event for LMND is its Q1 2026 earnings release, currently expected around May 5, 2026, with analyst consensus projecting an EPS of approximately -$0.58. Investors will be closely watching whether revenue guidance of $246–$251 million proves achievable and whether in-force premium growth continues its acceleration. The Tesla FSD insurance rollout beyond Arizona and Oregon will also be a closely tracked development, as geographic expansion could significantly broaden Lemonade's addressable market. Risks include ongoing adjusted EBITDA losses, competitive pressure from established insurers, potential regulatory complexity around autonomous vehicle data, and the stock's sensitivity to broader market sell-offs given its elevated valuation. Analysts hold a mixed consensus — recent upgrades from Morgan Stanley and Truist contrast with a majority of analysts still at Hold or Sell, suggesting the bull case is gaining traction but not yet broadly embraced.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
LMND broke above its upper Bollinger Band on March 16, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options. The A.I.dvisor looked at 38 similar instances where the stock broke above the upper band. In of the 38 cases the stock fell afterwards. This puts the odds of success at .
The Momentum Indicator moved below the 0 level on March 31, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on LMND as a result. In of 90 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for LMND turned negative on April 07, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 50 similar instances when the indicator turned negative. In of the 50 cases the stock turned lower in the days that followed. This puts the odds of success at .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where LMND declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where LMND advanced for three days, in of 263 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 134 cases where LMND Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. LMND’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: LMND's P/B Ratio (7.794) is very high in comparison to the industry average of (2.096). P/E Ratio (0.000) is within average values for comparable stocks, (14.024). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.828). LMND has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.040). LMND's P/S Ratio (5.456) is very high in comparison to the industry average of (1.417).
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. LMND’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 56, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
an insurance holding company, which engages in the provision of home and renters insurance services
Industry PropertyCasualtyInsurance